SINSIN PHARMACEUTICAL Co., LTD.
Sinsin Pharmaceutical sells medicated patches and OTC medicines through direct deals with over 13,000 pharmacies nationwide.
As of 2026-10-10, SINSIN PHARMACEUTICAL Co., LTD. has 6 Korean MFDS device approvals, 182 Korean MFDS drug approvals on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 1959, Sinsin Pharmaceutical listed on KOSDAQ in 2017 as an OTC medicine company specializing in medicated patches. It manufactures and sells about 100 OTC drugs and quasi-drugs including Sinsin Pasa Arex and other patches, liquid patches, spray patches, insect repellents, topical liquids, corn removers, ointments, and bandages. Pharmacies account for 49% of sales, with direct transactions across more than 13,000 retail pharmacies nationwide, while exports make up 14% of total sales, led by Southeast Asia followed by other Asia and Europe, with antipyretic patches and medicated patches as key export items.
Products & technology
- 신신파스 아렉스
- 물파스
- 에어파스
- 해열 패치
Regulatory approvals
data.go.kr182 Korean MFDS drug approvals · 1959–2026 / 6 Korean MFDS device approvals · 2005–2014
- MFDS drugJAHAYUN solution2026-09-07Drug · OTC · Approval202602665
- MFDS drugSINSINPAS19572026-07-02Drug · OTC · Notification202601928
- MFDS drugSINSINPASNEWGENPLASTER2026-05-28Drug · OTC · Notification202601542
- MFDS drugHemo M Tab.2026-04-02Drug · OTC · Notification202600939
- MFDS drugPain Relieving Liquid MULPAS2026-02-26Drug · OTC · Approval202600586
- MFDS drugSINSINPASNEWGENGEL2026-02-23Drug · OTC · Notification202600511
- MFDS drugSinsin Easymotion Tab.2025-11-04Drug · OTC · Notification202502853
- MFDS drugSINSIN GLUTATION TABLET2025-11-03Drug · OTC · Notification202502836
- MFDS drugSinsin Papave Tab.2025-09-26Drug · OTC · Notification202502555
- MFDS drugAcderm clear cleam2025-08-29Drug · OTC · Notification202502279
- MFDS drugSinsin Cetirizine Tab.(Cetifizine HCL)2025-07-30Drug · OTC · Notification202501994
- MFDS drugMuzomu Nail Solution2025-07-17Drug · OTC · Approval202501824
Show 68 more
- MFDS drugSinsin Actipi Tab.2025-07-07Drug · OTC · Notification202501686
- MFDS drugSinsin Folic Acid Tab.2025-07-04Drug · OTC · Notification202501670
- MFDS drugSINSINPAS Callus & Wart Remover Patch2025-07-03Drug · OTC · Approval202501654
- MFDS drugSinsin Scober Cap.2025-06-27Drug · OTC · Notification202501606
- MFDS drugDiclomax Gel2025-04-30Drug · OTC · Notification202501065
- MFDS drugAllenose capsule2025-04-28Drug · OTC · Notification202501013
- MFDS drugStomal Powder2025-04-21Drug · OTC · Notification202500941
- MFDS drugMulrindy Plaster2025-02-14Drug · OTC · Notification202500330
- MFDS drugGinkgo Bro Tab. 240mg2024-08-14Drug · OTC · Notification202401984
- MFDS drugMinoxi foam aerosol 5% (Minoxidil)2024-07-23Drug · OTC · Notification202401777
- MFDS drugSinsin Pas Hanbang Cataplasma2024-07-03Drug · OTC · Notification202401615
- MFDS drugLactoran Tab.2024-06-21Drug · OTC · Notification202401506
- MFDS drugPancre Tab.2024-06-13Drug · OTC · Notification202401440
- MFDS drugfuridios tablet(diosmin)2024-05-29Drug · OTC · Notification202401328
- MFDS drugSinsin Flex Tab.2024-05-16Drug · OTC · Notification202401187
- MFDS drugCaldimac Tab.2024-03-22Drug · OTC · Notification202400594
- MFDS drugAcdermgel(benzoylperoxide)2024-03-21Drug · OTC · Notification202400593
- MFDS drugSinsin Lidocaine Cataplasma 5%(for export)2024-02-05Drug · Prescription · Approval202400264
- MFDS drugDiclomax Plaster2023-08-22Drug · OTC · Notification202302480
- MFDS drugUp-tension Sol.2023-08-07Drug · OTC · Notification202302341
- MFDS drugi-Mc eye drops 1%2023-08-02Drug · OTC · Notification202302329
- MFDS drugSINSIN Oxybutynin Patch 36mgRevoked2023-07-28Drug · OTC · Approval202302260
- MFDS drugCool & Hot Combine Patch2023-06-22Drug · OTC · Approval202301915
- MFDS drugSinsin Rivastigmine Patch 52023-03-24Drug · Prescription · Approval202301019
- MFDS drugSinsin Rivastigmine Patch 102023-03-24Drug · Prescription · Approval202301020
- MFDS drugNo Sweat Sense Solution2023-03-03Drug · OTC · Approval202300750
- MFDS drugNo Sweat Solution2023-03-03Drug · OTC · Approval202300751
- MFDS drugEyesopt Eye Drops2022-11-28Drug · Prescription · Approval202204280
- MFDS drugSINSINPAS CORN Callus & Wart Remover2022-07-26Drug · OTC · Approval202203091
- MFDS drugSinsin Donepezil Solution 5mg, 10mg2022-07-18Drug · Prescription · Approval202202974
- MFDS drugMulrindy cool Solution2022-02-08Drug · OTC · Notification202200584
- MFDS drugSINSIN CARETAMIN TAB.2021-12-29Drug · OTC · Notification202108177
- MFDS drugSINSIN MELATONIN PATCH2021-12-15Drug · OTC · Approval202107984
- MFDS drugSINSINPAS AREX GEL PATCH2021-07-13Drug · OTC · Approval202105330
- MFDS drugSINSINPAS AREX LOTION2021-07-13Drug · OTC · Approval202105331
- MFDS drugSinsin Clear-View Soft Cap.Revoked2020-12-30Drug · OTC · Notification202009393
- MFDS drugMIYARISAN ANGEL2020-12-17Drug · OTC · Approval202008946
- MFDS drugIBUSTAR PLASTER2020-10-06Drug · OTC · Approval202006761
- MFDS drugSinsin UDCA Soft Cap.Revoked2020-06-08Drug · OTC · Notification202004279
- MFDS drugSinsin Fluneck Soft Ext.2020-06-04Drug · OTC · Notification202004223
- MFDS drugSinsin Complex UDCA Soft Cap.Revoked2020-05-21Drug · OTC · Notification202003682
- MFDS drugSinsin Rivastigmine Cap. 3.0mg2020-05-19Drug · Prescription · Approval202003635
- MFDS drugSinsin Rivastigmine Cap. 1.5mg2020-05-19Drug · Prescription · Approval202003636
- MFDS drugSinsin Rivastigmine Cap. 6.0mg2020-05-19Drug · Prescription · Approval202003637
- MFDS drugSinsin Rivastigmine Cap. 4.5mg2020-05-19Drug · Prescription · Approval202003638
- MFDS drugSinsin Samsoeum Sol.2020-04-14Drug · OTC · Notification202002621
- MFDS drugSinsin Galgeuntang Solution2020-04-14Drug · OTC · Notification202002622
- MFDS drugSinsin Ssangwhatang Sol.2020-04-14Drug · OTC · Notification202002623
- MFDS drugSinsin Socheongryongtang Sol.2020-04-14Drug · OTC · Notification202002624
- MFDS drugSinsin Difen Cool Hydro CataplasmaRevoked2019-12-26Drug · OTC · Approval201908656
- MFDS drugSinsin Gabapentin Cap. 300mgRevoked2019-12-02Drug · Prescription · Approval201908186
- MFDS drugSinsin Gabapentin Cap. 100mgRevoked2019-12-02Drug · Prescription · Approval201908187
- MFDS drugSinsin Pregabalin Cap. 150mgRevoked2019-11-07Drug · Prescription · Approval201907792
- MFDS drugPIROXTAR PLASTER2019-08-29Drug · OTC · Approval201906177
- MFDS drugSinsin Permethrin Cream2019-08-13Drug · Prescription · Notification201905706
- MFDS drugSinsin Donepezil Tab. 5mg2019-06-27Drug · Prescription · Approval201904404
- MFDS drugSinsin Donepezil Tab. 10mg2019-06-27Drug · Prescription · Approval201904405
- MFDS drugSinsin Memantine Tab.2019-05-31Drug · Prescription · Approval201903640
- MFDS drugSCARDERM CLEAR GEL2019-05-30Drug · OTC · Notification201903580
- MFDS drugSinsin Quetiapine Tab. 200mgRevoked2019-05-29Drug · Prescription · Approval201903551
- MFDS drugSinsin Quetiapine Tab. 25mg2019-05-21Drug · Prescription · Approval201903265
- MFDS drugSinsin Quetiapine Tab. 100mg2019-05-21Drug · Prescription · Approval201903266
- MFDS drugSinsin Escitalopram Tab. 20mg2019-05-15Drug · Prescription · Approval201903129
- MFDS drugSinsin Escitalopram Tab. 10mg2019-05-15Drug · Prescription · Approval201903130
- MFDS drugFenoclin Plaster Strong2019-05-02Drug · OTC · Notification201902832
- MFDS drugMuzomu Plus Gel2019-02-13Drug · OTC · Notification201900904
- MFDS drugSinsin Fluconazole Cap. 50mg2018-09-28Drug · Prescription · Approval201803870
- MFDS drugSinsin Finasteride Tab. 1mg2018-09-21Drug · Prescription · Approval201803800
Showing the 80 most recent of 188 records.
Clinical trials
data.go.kr5 MFDS clinical trial authorisations · 2013–2024 (Phase 1 3 · Phase 3 1 · Bioequivalence 1)
- Phase 3UIP6202024-07-15
1 trial site
- Phase 1SS2622024-05-27
1 trial site
- Phase 1UIP6202020-09-23
1 trial site
- Phase 1UI(PT)6202018-11-26
1 trial site
- Bioequivalence신신리바스티그민패취18mg(가칭)2013-05-16
2 trial sites
Key disclosures
KRX KIND via OpenDARTPatents
KIPRIS · applicant-matchedPublished · 2024-03 · Application 1020240041451
Published · 2023-11 · Application 1020230164943
Withdrawn · 2023-06 · Application 1020230083056
Published · 2023-03 · Application 1020230042380
Published · 2022-11 · Application 1020220145834
Published · 2022-07 · Application 1020220084684
Published · 2021-12 · Application 1020210186651
Published · 2021-11 · Application 1020210148349
Published · 2021-08 · Application 1020210108389
Withdrawn · 2021-07 · Application 1020210099631
Show 22 more patents
Withdrawn · 2020-10 · Application 1020200143933
Published · 2020-04 · Application 1020200052955
Registered · 2020-04 · Application 1020200052783
Withdrawn · 2020-04 · Application 1020200052947
Registered · 2020-02 · Application 1020200020249
Registered · 2019-10 · Application 1020190136808
Registered · 2019-06 · Application 1020190070239
Registered · 2018-10 · Application 1020180132547
Rejected · 2017-10 · Application 1020170143187
Registered · 2017-10 · Application 1020170138990
Registered · 2017-01 · Application 1020170013590
Registered · 2011-01 · Application 1020110008531
Expired · 2010-01 · Application 1020100006333
Expired · 2009-04 · Application 1020090032847
Rejected · 2003-11 · Application 1020030077373
Rejected · 2002-05 · Application 1020020027538
Expired · 1999-10 · Application 2019990021318
Expired · 1999-10 · Application 2019990021316
Rejected · 1999-06 · Application 1019990023321
Rejected · 1999-06 · Application 2019990009526
Expired · 1999-03 · Application 1019990007224
Expired · 1999-03 · Application 1019990007223
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIChatGPT-Userlive3
- OpenAIOAI-SearchBot84
- GoogleGoogleOther5
- PerplexityPerplexityBot3
- AnthropicClaudeBot2
- MicrosoftBingbot1
Measured since Aug 27, 2026 · 5 AI engines · last read Oct 9, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for SINSIN PHARMACEUTICAL Co., LTD. and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies approved for the same productsPharma & CDMO
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
KOSDAQ-listed pharmaceutical company behind the world's first oral paclitaxel Liporaxel (DHP107) and the Amalian dermal filler.
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded in 1980, Korean Drug produces the cold medicine Haben and the dementia drug Neuromed, along with other CNS disease treatments.
KOSDAQ-listed in-vitro diagnostics company selling PROTIA Allergy-Q allergy diagnostic products domestically and in 80+ countries.
Founded in 1978 and listed on the KOSDAQ in 2000, Jin Yang Pharmaceutical is a generic-drug-focused pharmaceutical company producing Sobunal and Octiran.
Founded in 1959 and listed on KOSPI in 1988, Jeil Pharma Holdings is a pharmaceutical holding company whose subsidiaries include Jeil Pharm.
KOSDAQ-listed molecular genetic diagnostics company providing NGS-based non-invasive prenatal testing (NIPT) under the MomGuard brand.
KOSPI-listed pharmaceutical company known for its anti-ulcer drug Noltec and leukemia treatment Supect (radotinib).
Holds manufacturing approvals for 42 point-of-care diagnostic reagents and devices in the IVD market.
Dong-A ST, spun off from Dong-A Socio Holdings in 2013 and KOSPI-listed, makes prescription drugs like Growtropin, Stillen, and Bacchus.
Founded in 1945, JW Pharmaceutical holds an original drug pipeline including Rivalo and Hemlibra, plus the IV nutrition product Winuf and OTC brand Hwakol.
Founded in 1966, KOSPI-listed PharmGen Science makes GI and cardiovascular prescription drugs plus health foods and beauty products.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition